secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001104659-24-061135
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira BioSciences issues $287.5M convertible notes, repurchases $200M of 2025 notes and $25M stock
--------------------------------------------------------------------------------

- Issued $250.0M (plus $37.5M option) of 2.125% Convertible Senior Notes due 2029; net proceeds ~$278.4M.
- Used ~$191.4M to repurchase $200M aggregate principal of outstanding 0.750% convertible notes due 2025.
- Used ~$25.0M to repurchase 837,240 shares of common stock.
- Entered into capped call transactions to reduce potential dilution upon conversion, with cap price ~$53.75/share.
- Initial conversion price ~$39.56/share, representing ~32.5% premium over closing price of $29.86 on May 9, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000110465924061135/0001104659-24-061135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000110465924061135/tm2414366d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-061135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer